Literature DB >> 10966286

Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria.

E E Oragui1, S Nadel, P Kyd, M Levin.   

Abstract

OBJECTIVES: Meningococcal septic shock is a devastating illness associated with an increase in vascular permeability leading to hypovolemia and accumulation of plasma proteins and fluid in tissues. The capillary leak syndrome is often associated with widespread thrombosis in the skin, limbs, and digits. We postulated that the increase in vascular permeability and the intravascular thrombosis might be caused by an inflammation-induced loss of endothelial and basement membrane glycosaminoglycans (GAGs), which play a role in the permeability and thromboresistant properties of the microvasculature.
DESIGN: Prospective, single-center observational study.
SETTING: University-affiliated meningococcal research unit and pediatric intensive care unit. PATIENTS: Eighteen children requiring intensive care for meningococcal sepsis, 18 children with steroid-responsive nephrotic syndrome, and 18 healthy control children.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Serum concentrations and urine excretion of glycosaminoglycans were measured and related to changes in glomerular permeability to plasma proteins. The size-distribution and nature of glycosaminoglycans were defined by Polyacrylamide Gel Electrophoresis and specific enzyme digestion. Urinary excretion of heparan sulfate, chondroitin-4-sulfate, and chondroitin-6-sulfate were significantly increased in meningococcal disease (MD) relative to healthy controls and children with steroid-responsive nephrotic syndrome. The urinary GAGs in MD were of similar size to those in controls when analyzed after pronase digestion. However, analysis of proteoglycan size before proteolytic digestion showed the urinary GAGs in MD were of lower molecular weight and unattached to proteins. The fractional excretion of albumin and immunoglobulin G in MD increased with severity of disease. Patients with severe or fatal MD had albumin clearances overlapping those seen in steroid-responsive nephrotic syndrome. There was a significant correlation between proteinuria in MD and urinary excretion of heparan sulfate (r2 = 0.611, p < .0001), chondroitin-4-sulfate (r2 = 0.721, p < .0001), and chondroitin-6-sulfate (r2 = 0.395, p < .0001).
CONCLUSIONS: The capillary leak in meningococcal disease is associated with increased plasma and urine concentrations of GAGs, which may be proteolytically cleaved from endothelial and basement membrane sites. The correlation between the severity of protein leakage and the urine excretion of GAGs suggests that loss of GAGs may be causally related to the increase in permeability to proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966286     DOI: 10.1097/00003246-200008000-00054

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

Review 1.  Pathophysiology of meningococcal meningitis and septicaemia.

Authors:  N Pathan; S N Faust; M Levin
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome.

Authors:  Eric P Schmidt; Katherine H Overdier; Xiaojun Sun; Lei Lin; Xinyue Liu; Yimu Yang; Lee Anne Ammons; Terra D Hiller; Matt A Suflita; Yanlei Yu; Yin Chen; Fuming Zhang; Clay Cothren Burlew; Charles L Edelstein; Ivor S Douglas; Robert J Linhardt
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

3.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Authors:  M T Schram; N Chaturvedi; C G Schalkwijk; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

4.  Low Levels of Factor H Family Proteins During Meningococcal Disease Indicate Systemic Processes Rather Than Specific Depletion by Neisseria meningitidis.

Authors:  Anna E van Beek; Richard B Pouw; Victoria J Wright; Neneh Sallah; David Inwald; Clive Hoggart; Mieke C Brouwer; Rachel Galassini; John Thomas; Leo Calvo-Bado; Colin G Fink; Ilse Jongerius; Martin Hibberd; Diana Wouters; Michael Levin; Taco W Kuijpers
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 5.  Endothelial and Microcirculatory Function and Dysfunction in Sepsis.

Authors:  James F Colbert; Eric P Schmidt
Journal:  Clin Chest Med       Date:  2016-03-04       Impact factor: 2.878

6.  Dextran fractional clearance studies in acute dengue infection.

Authors:  Julie Nguyen-Pouplin; Thomas Pouplin; Toi Pham Van; Trung Dinh The; Dung Nguyen Thi; Jeremy Farrar; Hien Tran Tinh; Bridget Wills
Journal:  PLoS Negl Trop Dis       Date:  2011-08-23

7.  Serum heparan sulfate levels are elevated in endotoxemia.

Authors:  Klaus F Hofmann-Kiefer; G I Kemming; D Chappell; M Flondor; H Kisch-Wedel; A Hauser; S Pallivathukal; P Conzen; M Rehm
Journal:  Eur J Med Res       Date:  2009       Impact factor: 2.175

8.  Sepsis induces albuminuria and alterations in the glomerular filtration barrier: a morphofunctional study in the rat.

Authors:  Chiara Adembri; Eleonora Sgambati; Luca Vitali; Valentina Selmi; Martina Margheri; Alessia Tani; Laura Bonaccini; Daniele Nosi; Anna L Caldini; Lucia Formigli; Angelo R De Gaudio
Journal:  Crit Care       Date:  2011-11-22       Impact factor: 9.097

9.  Endothelial Glycocalyx Layer: A Possible Therapeutic Target for Acute Lung Injury during Lung Resection.

Authors:  JiaWan Wang; AnShi Wu; Yan Wu
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

10.  Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS.

Authors:  Longxiang Su; Lichao Cao; Ruo Zhou; Zhaoxu Jiang; Kun Xiao; Weijing Kong; Huijuan Wang; Jie Deng; Bo Wen; Fengji Tan; Yong Zhang; Lixin Xie
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.